Key Opinion Leaders to Present at the Respiratory Drug Delivery Conference

KENSINGTON, U.K. - Aug. 12, 2019 - PRLog -- The conference aims to bring together clinical researchers, respiratory drug manufacturers and solution providers to discuss the current research and developments in providing appropriate long-term treatments that adhere to patient's needs, analysing the success of digital medical devices and connective health technology in aiding the diagnosis of severe asthma and COPD.

This year, attendees will have the opportunity to network and learn from key opinion leaders including:

Dr Alison Moore, Clinical Development Manager, GSK

Ph.D Gunilla Petersson, Science and Innovation Director, Astrazeneca

Mr Herbert Wachtel, Senior Principal Scientist, Boehringer Ingelheim

Mr Mark Milton-Edwards, Head of Product & Health Solutions, Digital Health, Teva Pharmaceuticals

Dr Orla Ni Ogain, Pharmaceutical Assessor, Medicines & Healthcare products Regulatory Agency (MHRA)

Professor Tim Higenbottam, President of the Faculty of Pharmaceutical Medicine, Faculty of Pharmaceutical Medicine

Mr Mayur Patel, Leading innovative medical and combination product development, PA Consulting

Dr Dave Lewis, Aerosol Science Director, Chiesi Ltd

Professor Chris Corrigan, Professor of Asthma, Allergy and Immunology, Kings College London

Dr Jorge Bernardino de la Serna, Senior Lecturer, Inhalation, Toxicology and Pharmacology, Imperial College London

Ms Aljoscha Koenneke, PhD Pharmacist, Institute of Biopharmaceutics and Pharmaceutical Technology, Saarland University

The final brochure, with the full agenda and speaker line-up, is available to download online at www.respiratorydrugdelivery.com/prlog4

Plus, key conference highlights for 2019 include:

·         Hear updates from pharmaceutical companies on assessing the strategies to transform disease management through drug combinations, devices and inhaled biologic treatments

·         Discuss the issues associated within pricing pressure of Asthma and COPD inhalation products

·         Explore the current novel technologies and therapeutics aimed to optimize the delivery of respiratory drugs such as nanoparticle-based drug delivery

·         Gain insight into the strategies being implemented to digital connective inhalation to improve patient adherence

For those interested in attending the conference, an early bird sale of £300 is available for bookings made before 30^th September. Registrations can be made online at www.respiratorydrugdelivery.com/prlog4

Respiratory Drug Delivery

5^th – 6^th December 2019

Copthorne Tara Hotel, London, UK

For delegate enquiries please contact Fateja Begum on +44 (0) 20 7827 6184 or fbegum@smi-online.co.uk

For sponsorship enquiries please contact Alia Malick on +44 (0) 207 827 6168 or amalick@smi-online.co.uk